Applicant, as named in the Orange Book

Urogen Pharma

Next listed expiry: Jelmyto on 20 Jan 2031. 2 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Jelmyto mitomycin	mitomycin	211728	20 Jan 2031	patent
Zusduri mitomycin	mitomycin	215793	25 Jul 2044	patent, carve-out possible

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.